Liver Tumor Board (On-demand)
- Reviews the work-up, treatment options, management, follow-up and outcomes of both primary and metastatic hepatic malignancies with a focus on hepatocellular carcinoma, metastatic neuroendorine tumors, metastatic colorectal cancer and cholangiocarcinoma.
- Originally presented at SIR 2017 Annual Scientific Meeting
- Expires Sept. 30, 2020
ITEM DETAILS:
This course reviews the work-up, treatment options, management, follow-up and outcomes of both primary and metastatic hepatic malignancies with a focus on hepatocellular carcinoma, metastatic neuroendorine tumors, metastatic colorectal cancer and cholangiocarcinoma. The overall goal is to improved patient care by increasing the learner’s competency and knowledge of the management of different hepatic malignancies, both primary and metastatic, the treatment options with a focus on liver directed therapies, and follow-up.
This program is designed to meet the educational needs of interventional radiologists, oncologists, and all other physicians at all levels with special interest in oncologic interventions, especially liver tumors.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the different imaging findings of primary liver malignancies and metastatic disease.
- Recognize the importance of multidisciplinary approach to treating patients with liver tumors.
- Distinguish the best therapy for each patient depending on the type of tumor, location, extent or disease, and functional status.
Speaker Information
Coordinators/Speakers:
Daniel B. Brown, MD, FSIR; Vanderbilt University Medical Center
Matthew S. Johnson, MD, FSIR; Indiana University
William S. Rilling, MD, FSIR; Medical College of Wisconsin
Riccardo A. Lencioni, MD, FSIR; University of Miami
Reviews
There are no reviews yet.